Charles River Laboratories (CRL)

Cost of Revenue

$2.71B

TTM · Period ending: · USD

CRL logo

CRL Cost of Revenue

Latest reported$2.71B
CRL TTM Cost of Revenue ($188.76M → $2.71B)
High-resolution chart · PNG

CRL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Charles River Laboratories Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
2,709,647,000
2,744,011,000
2,693,936,000
2,725,869,000
2,720,551,000
2,717,887,000
2,718,168,000
2,649,254,000
2,653,295,000
2,641,851,000
2,626,853,000
2,678,421,000
2,632,572,000
2,588,017,000
2,513,409,000
2,370,388,000
2,310,164,000
2,266,345,000
2,205,522,000
2,138,606,000
2,033,922,000
1,911,682,000
1,850,392,000
1,788,194,000
1,756,003,000
1,725,121,000
1,662,915,000
1,609,204,000
1,556,464,000
1,506,320,000
1,426,029,000
1,361,644,000
1,279,934,000
1,194,418,000
1,156,328,000
1,132,508,000
1,114,573,000
1,095,077,000
1,034,766,000
961,134,000
903,074,000
845,556,000
832,210,000
828,537,000
826,446,000
835,201,000
825,002,000
812,230,000
795,134,000
769,952,000
766,424,000
755,160,000
748,384,000
739,159,000
733,901,000
738,728,000
738,164,000
738,969,000
740,405,000
724,273,000
719,795,000
725,680,000
735,557,000
756,555,000
767,091,000
772,959,000
773,183,000
777,295,000
798,331,000
818,782,000
832,784,000
833,677,000
811,785,000
784,117,000
752,435,000
722,165,000
694,498,000
668,768,000
651,778,000
667,393,000
672,140,000
660,677,000
671,152,000
637,883,000
577,367,000
533,653,000
468,351,000
412,444,000
400,517,000
389,724,000
380,058,000
373,419,000
366,606,000
355,928,000
345,646,000
338,337,000
330,922,000
319,871,000
298,379,000
272,287,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.